Changes of FASH ultrasound findings in TB-HIV patients during anti-tuberculosis treatment

Int J Tuberc Lung Dis. 2014 Jul;18(7):837-9. doi: 10.5588/ijtld.13.0029.


Ultrasound findings of extra-pulmonary tuberculosis (TB) have been well-described, particularly in human immunodeficiency virus (HIV) co-infected patients, and are often used as a basis of diagnosis in high-prevalence settings. Changes in findings during anti-tuberculosis treatment are less well documented. We present a single-centre case series of 21 TB-HIV co-infected individuals with typical ultrasound findings present at baseline. In 16/21 (76%) patients, all findings had resolved by month 3 of treatment. In patients with persistent ultrasound findings at 3 months, non-adherence, drug resistance, chronic disease, immune-reconstitution inflammatory syndrome and alternative diagnoses were identified. Follow-up ultrasound at month 3 may help identify high-risk cases.

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Bacterial
  • Female
  • Follow-Up Studies
  • HIV Infections / complications*
  • Humans
  • Male
  • Medication Adherence*
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis / diagnostic imaging*
  • Tuberculosis / drug therapy
  • Ultrasonography


  • Antitubercular Agents